Lüderitz B, Pfeiffer D, Tebbenjohanns J, Jung W
Department of Cardiology, University of Bonn, Germany.
Am J Cardiol. 1996 Jan 25;77(3):45A-52A. doi: 10.1016/s0002-9149(97)89117-5.
Nonpharmacologic tools to treat atrial fibrillation (AF) are direct current cardioversion, radiofrequency (RF) current catheter ablation, antiarrhythmic surgery, pacing, and atrial defibrillation. In patients with sustained AF, when no cause can be found for AF or when the associated disease is mild, an attempt should be made to restore sinus rhythm. Electrical cardioversion by synchronized direct current shock can be attempted when drugs have failed and is the first choice in acutely ill patients. Virtually all patients should be anticoagulated. Temporary pacing should be available in patients with evidence of previous bradycardia. Although efficacy may be improved in patients pretreated with antiarrhythmic drugs, there is a considerable risk of adverse events. In AF and sinus node dysfunction, both pacing and antiarrhythmic drugs may be necessary. Pacing should be atrial or dual chamber, since ventricular pacing provokes AF. Failure to control the ventricular rate in AF can be treated by RF: atrioventricular (AV) node ablation, ablation of accessory pathways in preexcitation syndrome with AF, modulation of AV node, or ablation of AF. Antiarrhythmic surgery is a major procedure and may be the therapy of last resort in AF: the so-called corridor procedure isolates the fibrillating atria from a strip of tissue connecting the sinus and AV nodes. The maze procedure attempts to abolish AF by channeling the atrial activation between a series of incisions. In patients with chronic AF, internal cardioversion should be attempted if conventional transthoracic electrical cardioversion is ineffective. Several studies demonstrated the feasibility and efficacy of internal atrial defibrillation in selected patients with recent onset, as well as with chronic, AF. An implantable atrial defibrillator--as a stand-alone device or as part of a whole heart cardioverter--might be an option in the future. Nonpharmacologic tools play only a minor role in the management of paroxysmal and chronic AF. If symptoms persist despite pharmacologic therapy and other causes of persisting symptoms are excluded, consideration should be given to cardiac pacing, RF catheter treatment, or surgery. in some cases nonpharmacologic therapy of the AV node must be followed by implantation of a permanent pacemaker (due to complete AV block) and anticoagulation (due to persistence of underlying AF.
治疗心房颤动(AF)的非药物手段包括直流电复律、射频(RF)电流导管消融、抗心律失常手术、起搏和心房除颤。对于持续性AF患者,若未发现AF病因或相关疾病较轻,应尝试恢复窦性心律。当药物治疗失败时,可尝试通过同步直流电电击进行电复律,这是急性病患者的首选方法。几乎所有患者都应接受抗凝治疗。有既往心动过缓证据的患者应备有临时起搏设备。尽管预先使用抗心律失常药物治疗可能会提高疗效,但不良事件风险相当高。对于AF合并窦房结功能障碍的患者,起搏和抗心律失常药物可能都有必要。起搏应为心房或双腔起搏,因为心室起搏会诱发AF。AF时心室率控制不佳可通过射频治疗:房室(AV)结消融、预激综合征合并AF时旁路消融、AV结调制或AF消融。抗心律失常手术是一项大型手术,可能是AF的最后治疗手段:所谓的走廊手术将颤动的心房与连接窦房结和房室结的一条组织带隔离开来。迷宫手术试图通过在一系列切口之间引导心房激动来消除AF。对于慢性AF患者,如果传统经胸电复律无效,应尝试体内复律。多项研究证明了体内心房除颤在近期发作以及慢性AF的特定患者中的可行性和有效性。植入式心房除颤器——作为独立设备或作为全心脏心脏复律器的一部分——未来可能是一种选择。非药物手段在阵发性和慢性AF的管理中仅起次要作用。如果药物治疗后症状仍持续且排除了其他导致症状持续的原因,则应考虑心脏起搏、射频导管治疗或手术。在某些情况下,AV结的非药物治疗后必须植入永久性起搏器(由于完全性房室传导阻滞)并进行抗凝治疗(由于潜在AF持续存在)。